Rechallenge With Nivolumab After Vemurafenib Treatment of Initially Nivolumab-Resistant Advanced Melanoma

This case report describes a patient with advanced melanoma initially resistant to nivolumab therapy, treated with vemurafenib, and then rechallenged with nivolumab after development of vemurafenib-related adverse effects.

https://ift.tt/2IdQBzx